Navigation Links
NxStage to Report Second Quarter 2009 Financial Results
Date:7/20/2009

LAWRENCE, Mass., July 20 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the second quarter ended June 30, 2009 on Wednesday, August 5, 2009 before the opening of the financial markets.

NxStage will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, August 5, 2009 to discuss its second quarter financial results. To listen to the conference call, please dial 866-730-5765 (domestic) or 857-350-1589 (international). The passcode is 18840646. The call will also be webcast LIVE and can be accessed via the investor relations section of the Company's website at www.nxstage.com/ir.cfm.

A replay of the conference call will be available 3 hours after the start of the call through August 19, 2009. To access the replay dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter passcode 52867664. An online archive of the conference call can be accessed via the investor relations section of the Company's website at www.nxstage.com/ir.cfm.

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward- looking statements. The forward-looking statements in this release include NxStage's plan to release its financial results on August 5, 2009. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, unexpected difficulty in closing the company's financial books for the quarter and other factors that are discussed in NxStage's Quarterly Report on Form 10-Q for the period ended March 31, 2009 filed with the SEC. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: Kristen K. Sheppard, Esq.VP, Investor Relations ksheppard@nxstage.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
2. NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical
3. NxStage to Present at the William Blair Growth Stock Conference
4. NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) Technology
5. NxStage Announces Strategic Business Alliance with Asahi Kasei Kuraray Medical
6. NxStage Ranked Fourth Largest Revenue Gaining Company in Massachusetts for 2008
7. NxStage to Present at the Canaccord Adams Diabetes & Obesity Conference
8. NxStage Announces Credit Facility Amendment
9. NxStage Reports Fourth Quarter and Full Year 2008 Financial Results
10. NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year
11. iSirona Signs Reference Selling Agreement with NxStage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... Los Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... bariatric surgeons have noted that, less than 1% of United Kingdom residents who could ... the UK’s National Health Service (NHS) increases the number of bariatric procedures it offers ...
(Date:5/23/2016)... ... ... Researchers can find themselves in a state of semi-autopilot while pipetting, perhaps ... yield big benefits. Scientists might be surprised to learn how acquiring specific pipetting techniques ... the risk of contamination when working with eukaryotic cells. , Eppendorf is sponsoring a ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... objectification, according to Georgia State University researchers. , In a recent ... fifth, sixth and seventh grades shared their experiences with strained relationships, recurring ...
(Date:5/23/2016)... Austin, Texas (PRWEB) , ... May 23, 2016 ... ... May 23, the Texas Veterinary Medical Association (TVMA) reminds pet owners that intervening ... a serious emergency. Heatstroke occurs when a pet’s normal body mechanisms cannot keep ...
(Date:5/23/2016)... ... 23, 2016 , ... ComplianceOnline, the leading governance, risk and compliance advisory network ... September 15 and 16, 2016 in San Diego, CA. The two day summit ... be one of the largest gatherings of medical device companies, suppliers, professionals and experts ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
(Date:5/20/2016)... , May 20, 2016 ... veteran investors believe that the industry is not far ... and today ActiveWallSt.com featured the following four equities: Anacor ... (NASDAQ: ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free ...
(Date:5/19/2016)... PARIS , May 19,2016 ... Activities at Digestive Disease Week Meeting and 91 ... Society Mauna Kea Technologies (Euronext: MKEA, ... laser endomicroscopy platform, today announced that its Cellvizio ... meeting focused on gastroenterology during the month of ...
Breaking Medicine Technology: